Alanine 0 7 0 7 B-clinical_variable
aminotransferase 8 24 8 24 I-clinical_variable
( 25 26 25 26 I-clinical_variable
ALT 26 29 26 29 I-clinical_variable
) 29 30 29 30 I-clinical_variable
> 31 32 31 32 O
3X 33 35 33 35 B-lower_bound
ULN 36 39 36 39 I-lower_bound

Ambulatory 0 10 40 50 O
outpatients 11 22 51 62 O
with 23 27 63 67 O
breast 28 34 68 74 O
( 35 36 75 76 O
including 36 45 76 85 O
ductal 46 52 86 92 B-cancer
carcinoma 53 62 93 102 I-cancer
in 63 65 103 105 I-cancer
situ 66 70 106 110 I-cancer
[ 71 72 111 112 I-cancer
DCIS 72 76 112 116 I-cancer
] 76 77 116 117 I-cancer
) 77 78 117 118 O
cancer 79 85 119 125 B-cancer

Aspartate 0 9 126 135 B-clinical_variable
aminotransferase 10 26 136 152 I-clinical_variable
( 27 28 153 154 I-clinical_variable
AST 28 31 154 157 I-clinical_variable
) 31 32 157 158 I-clinical_variable
> 33 34 159 160 O
3X 35 37 161 163 B-lower_bound
upper 38 43 164 169 I-lower_bound
limit 44 49 170 175 I-lower_bound
of 50 52 176 178 I-lower_bound
normal 53 59 179 185 I-lower_bound
( 60 61 186 187 I-lower_bound
ULN 61 64 187 190 I-lower_bound
) 64 65 190 191 I-lower_bound

Bilirubin 0 9 192 201 B-clinical_variable
> 10 11 202 203 O
1X 12 14 204 206 B-lower_bound
ULN 15 18 207 210 I-lower_bound

Current 0 7 211 218 O
use 8 11 219 222 O
of 12 14 223 225 O
American 15 23 226 234 B-treatment
ginseng 24 31 235 242 I-treatment
, 31 32 242 243 O
remelteon 33 42 244 253 B-treatment
, 42 43 253 254 O
or 44 46 255 257 O
warfarin 47 55 258 266 B-treatment

Depression 0 10 267 277 B-clinical_variable
≥ 11 12 278 279 O
grade 13 18 280 285 B-lower_bound
2 19 20 286 287 I-lower_bound

ECOG 0 4 288 292 B-clinical_variable
performance 5 16 293 304 I-clinical_variable
status 17 23 305 311 I-clinical_variable
<3 24 26 312 314 O

Fatigue 0 7 315 322 O
brought 8 15 323 330 O
on 16 18 331 333 O
by 19 21 334 336 O
conditions 22 32 337 347 O
other 33 38 348 353 O
than 39 43 354 358 O
cancer 44 50 359 365 B-cancer

Hemoglobin 0 10 366 376 B-clinical_variable
≥ 11 12 377 378 O
9 13 14 379 380 B-lower_bound
g 15 16 381 382 I-lower_bound
/ 16 17 382 383 I-lower_bound
dL 17 19 383 385 I-lower_bound

Patients 0 8 386 394 O
to 9 11 395 397 O
be 12 14 398 400 O
treated 15 22 401 408 O
with 23 27 409 413 O
RT 28 30 414 416 B-treatment
for 31 34 417 420 O
curative 35 43 421 429 O
intent 44 50 430 436 O

Patients 0 8 437 445 O
with 9 13 446 450 O
a 14 15 451 452 O
creatinine 16 26 453 463 B-clinical_variable
clearance 27 36 464 473 I-clinical_variable
< 37 38 474 475 O
30 38 40 475 477 B-upper_bound
mL 41 43 478 480 I-upper_bound
/ 43 44 480 481 I-upper_bound
min 44 47 481 484 I-upper_bound

Subjects 0 8 485 493 O
who 9 12 494 497 O
are 13 16 498 501 O
currently 17 26 502 511 O
taking 27 33 512 518 O
melatonin 34 43 519 528 B-treatment
must 44 48 529 533 O
discontinue 49 60 534 545 O
melatonin 61 70 546 555 O
for 71 74 556 559 O
5 75 76 560 561 B-upper_bound
days 77 81 562 566 I-upper_bound
before 82 88 567 573 I-upper_bound
enrolling 89 98 574 583 O
in 99 101 584 586 O
the 102 105 587 590 O
study 106 111 591 596 O

Use 0 3 597 600 O
of 4 6 601 603 O
systemic 7 15 604 612 B-treatment
steroids 16 24 613 621 I-treatment
, 24 25 621 622 O
or 26 28 623 625 O
other 29 34 626 631 O
pharmacological 35 50 632 647 B-treatment
agents 51 57 648 654 I-treatment
such 58 62 655 659 O
as 63 65 660 662 O
methylphenidate 66 81 663 678 B-treatment
for 82 85 679 682 O
cancer 86 92 683 689 B-cancer
- 92 93 689 690 I-cancer
related 93 100 690 697 I-cancer
fatigue 101 108 698 705 I-cancer

Women 0 5 706 711 B-gender
≥18 6 9 712 715 O
years 10 15 716 721 I-lower_bound
of 16 18 722 724 O
age 19 22 725 728 B-age

chronic 0 7 729 736 B-chronic_disease
obstructive 8 19 737 748 I-chronic_disease
pulmonary 20 29 749 758 I-chronic_disease
disease 30 37 759 766 I-chronic_disease
requiring 38 47 767 776 O
oxygen 48 54 777 783 O
replacement 55 66 784 795 O

decompensated 0 13 796 809 B-chronic_disease
congestive 14 24 810 820 I-chronic_disease
heart 25 30 821 826 I-chronic_disease
failure 31 38 827 834 I-chronic_disease

hypercalcemia 0 13 835 848 B-chronic_disease
( 14 15 849 850 O
calcium 15 22 850 857 B-clinical_variable
> 23 24 858 859 O
11 24 26 859 861 B-lower_bound
mg 27 29 862 864 I-lower_bound
/ 29 30 864 865 I-lower_bound
dL 30 32 865 867 I-lower_bound
) 32 33 867 868 O
Ca 34 36 869 871 O
= 37 38 872 873 O
SerumCa 39 46 874 881 O
+ 47 48 882 883 O
0.8 49 52 884 887 O
* 53 54 888 889 O
( 55 56 890 891 O
NormalAlbumin 56 69 891 904 O
- 70 71 905 906 O
PatientAlbumin 72 86 907 921 O
) 86 87 921 922 O

uncontrolled 0 12 923 935 O
hypothyroidism 13 27 936 950 B-chronic_disease
( 28 29 951 952 O
TSH 29 32 952 955 B-clinical_variable
> 33 34 956 957 O
10 34 36 957 959 B-lower_bound
IU 37 39 960 962 I-lower_bound
) 39 40 962 963 O

willing 0 7 964 971 B-contraception_consent
to 8 10 972 974 I-contraception_consent
use 11 14 975 978 I-contraception_consent
an 15 17 979 981 I-contraception_consent
acceptable 18 28 982 992 I-contraception_consent
method 29 35 993 999 I-contraception_consent
of 36 38 1000 1002 I-contraception_consent
birth 39 44 1003 1008 I-contraception_consent
control 45 52 1009 1016 I-contraception_consent
during 53 59 1017 1023 O
study 60 65 1024 1029 O
treatment 66 75 1030 1039 B-treatment
and 76 79 1040 1043 O
for 80 83 1044 1047 O
3 84 85 1048 1049 B-upper_bound
months 86 92 1050 1056 I-upper_bound
afterwards 93 103 1057 1067 O

